| Product Name |
Dabigatran Inhouse Impurity 22 / Methyl 3-[[2-[[4-(N'-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines |
| CAS No |
211915-00-3 |
| Catalog Number |
GS.01.DAB.132 |
| Chemical Name/Synonyms |
(Z)-Methyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl) amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| Molecular Weight |
613.71 |
| Molecular Formula |
C33H39N7O5 |
| Purity |
NLT 95 % |
| Appearance |
White to Pale Beige Solid |
| Solubility |
Acetonitrile, DMSO |
| Applications |
Used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. |
| Inventory Status |
QC Pending
|
